The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease - Steffel, J; Eikelboom, JW; Anand, SS (Circulation, 2020)
et al.